Skip to main content
. 2020 Jun 15;5(25):15083–15094. doi: 10.1021/acsomega.0c00912

Figure 7.

Figure 7

Optical images of agar plates characteristic of the antibacterial activities of SBA-15/PDA, SBA-15/PDA/Ag, CCM@SBA-15/PDA, and CCM@SBA-15/PDA/Ag against E. coli (A) and S. aureus (B). Assay conditions: 100 μL of 10 mg/mL nanocomposite dispersions were added to the plate with 10 μL of E. coli inoculated (∼105 cfu/mL); 200 μL of 10 mg/mL nanocomposite dispersions were added to the plate with 10 μL of S. aureus inoculated (∼105 CFU/mL). Scale bar: 20 mm.